Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Biological Identity of Nanoparticles in Vivo: Clinical Implications of the Protein Corona Publisher Pubmed



Caracciolo G1 ; Farokhzad OC2, 3 ; Mahmoudi M2, 4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Molecular Medicine, ‘Sapienza’ University of Rome, Rome, 00185, Italy
  2. 2. Laboratory of Nanomedicine and Biomaterials, Harvard Medical School, Department of Anesthesiology, Brigham and Women's Hospital, Boston, 02115, MA, United States
  3. 3. King Abdulaziz University, Jeddah, 21589, Saudi Arabia
  4. 4. Nanotechnology Research Center and Department of Nanotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, 14155-6451, Iran

Source: Trends in Biotechnology Published:2017


Abstract

Despite the advances in biomedical applications of nanoparticle (NP) and numerous publications, few NPs have made it to clinical trials and even fewer have reached clinical practice. This wide gap between bench discoveries and clinical applications is mainly because of our limited understanding of the biological identity of NPs. In physiological environments, NPs are coated by a ‘protein corona’ (PC), critically affecting physiological and therapeutic responses. To date, nearly all studies attempting to characterize the PC have been conducted in vitro. Here, we review recent advances in our understanding of the in vivo PC. We also discuss recent developments of quantitative models to predict biological interactions and how they offer new opportunities for the clinical translation of NPs. © 2016 Elsevier Ltd
Related Docs
View other Related Docs
1. Protein Corona Variation in Nanoparticles Revisited: A Dynamic Grouping Strategy, Colloids and Surfaces B: Biointerfaces (2019)
2. Regulation of Macrophage Recognition Through the Interplay of Nanoparticle Surface Functionality and Protein Corona, ACS Nano (2016)
3. Protein Corona: Opportunities and Challenges, International Journal of Biochemistry and Cell Biology (2016)
4. Exploring Cellular Interactions of Liposomes Using Protein Corona Fingerprints and Physicochemical Properties, ACS Nano (2016)
5. Multiscale Technologies for Treatment of Ischemic Cardiomyopathy, Nature Nanotechnology (2017)
6. Nanoparticles and Biological Environment Interactions, Advanced Structured Materials (2019)
7. The Importance of Selecting a Proper Biological Milieu for Protein Corona Analysis in Vitro: Human Plasma Versus Human Serum, International Journal of Biochemistry and Cell Biology (2016)
8. Gold Nanoparticles for Biomedical Imaging and Their Biological Response, New Developments in Gold Nanomaterials Research (2016)
Experts (# of related papers)
View all Related Experts
Mohamad Raoufi (12)
Fatemeh Atyabi (10)
Other Related Docs
9. Engineering the Nanoparticle-Protein Interface for Cancer Therapeutics, Cancer Treatment and Research (2015)
10. Photothermal Effects on Protein Adsorption Dynamics of Pegylated Gold Nanorods, Applied Materials Today (2019)
11. Disease Specific Protein Corona, Progress in Biomedical Optics and Imaging - Proceedings of SPIE (2015)
12. Nanoscale Technologies for Prevention and Treatment of Heart Failure: Challenges and Opportunities, Chemical Reviews (2019)
13. Targeted Superparamagnetic Iron Oxide Nanoparticles for Early Detection of Cancer: Possibilities and Challenges, Nanomedicine: Nanotechnology# Biology# and Medicine (2016)
14. Biomolecular Corona Dictates Aβ Fibrillation Process, ACS Chemical Neuroscience (2018)
15. The Impact of Protein Corona on the Biological Behavior of Targeting Nanomedicines, International Journal of Pharmaceutics (2022)
16. Synthetic and Biological Identities of Polymeric Nanoparticles Influencing the Cellular Delivery: An Immunological Link, Journal of Colloid and Interface Science (2019)
17. Molecular Interaction of Fibrinogen With Zeolite Nanoparticles, Scientific Reports (2019)
18. Protein Corona: Challenges and Opportunities for Cancer Therapy, Functionalized Nanomaterials for Cancer Research: Applications in Treatments# Tools and Devices (2024)
19. Dual Nano-Sized Contrast Agents in Pet/Mri: A Systematic Review, Contrast Media and Molecular Imaging (2016)
20. Nanotoxicology: Advances and Pitfalls in Research Methodology, Nanomedicine (2015)
21. Impact of Protein Pre-Coating on the Protein Corona Composition and Nanoparticle Cellular Uptake, Biomaterials (2016)
22. Biomedical Applications of Superparamagnetic Nanoparticles in Molecular Scale, Current Organic Chemistry (2015)
23. Sensing of Alzheimer's Disease and Multiple Sclerosis Using Nano-Bio Interfaces, Journal of Alzheimer's Disease (2017)
24. Bypassing Protein Corona Issue on Active Targeting: Zwitterionic Coatings Dictate Specific Interactions of Targeting Moieties and Cell Receptors, ACS Applied Materials and Interfaces (2016)
25. Crucial Role of the Protein Corona for the Specific Targeting of Nanoparticles, Nanomedicine (2015)
26. Identification of Nanoparticles With a Colorimetric Sensor Array, ACS Sensors (2016)
27. Unveiling the Theranostic Potential of Spions in Alzheimer's Disease Management, Journal of Psychiatric Research (2024)
28. The Bio-Interface Between Functionalized Au Nr@Go Nanoplatforms With Protein Corona and Their Impact on Delivery and Release System, Colloids and Surfaces B: Biointerfaces (2019)
29. Does Pharmacodynamics of Drugs Change After Presenting Them As Na-Noparticles Like Their Pharmacokinetics?, Current Drug Targets (2020)
30. Pegylated Magnetic Mesoporous Silica Nanoparticles Decorated With As1411 Aptamer As a Targeting Delivery System for Cytotoxic Agents, Pharmaceutical Development and Technology (2019)
31. Misinterpretation in Nanotoxicology: A Personal Perspective, Chemical Research in Toxicology (2016)
32. Transferrin Receptor-Mediated Liposomal Drug Delivery: Recent Trends in Targeted Therapy of Cancer, Expert Opinion on Drug Delivery (2022)
33. Zeolite Nanoparticles Inhibit Aβ-Fibrinogen Interaction and Formation of a Consequent Abnormal Structural Clot, ACS Applied Materials and Interfaces (2016)
34. Protein Corona Hampers Targeting Potential of Muc1 Aptamer Functionalized Sn-38 Core-Shell Nanoparticles, International Journal of Pharmaceutics (2015)
35. Novel Therapeutic Strategies for Alzheimer's Disease: Implications From Cell-Based Therapy and Nanotherapy, Nanomedicine: Nanotechnology# Biology# and Medicine (2020)
36. Biocompatibility and Nanostructured Materials: Applications in Nanomedicine, Artificial Cells# Nanomedicine and Biotechnology (2017)
37. Monoclonal Antibody Conjugated Magnetic Nanoparticles Could Target Muc-1-Positive Cells in Vitro But Not in Vivo, Contrast Media and Molecular Imaging (2015)
38. Health Concerns of Various Nanoparticles: A Review of Their in Vitro and in Vivo Toxicity, Nanomaterials (2018)
39. The Effect of Fibronectin Coating on Protein Corona Structure and Cellular Uptake of Single-Walled Carbon Nanotubes, Precision Nanomedicine (2020)
40. Superparamagnetic Iron Oxide Nanoparticles for in Vivo Molecular and Cellular Imaging, Contrast Media and Molecular Imaging (2015)
41. What We Need to Know About Liposomes As Drug Nanocarriers: An Updated Review, Advanced Pharmaceutical Bulletin (2023)
42. Theranostic Muc-1 Aptamer Targeted Gold Coated Superparamagnetic Iron Oxide Nanoparticles for Magnetic Resonance Imaging and Photothermal Therapy of Colon Cancer, Colloids and Surfaces B: Biointerfaces (2016)
43. Targeting Tumorigenicity of Breast Cancer Stem Cells Using Saha/Wnt-B Catenin Antagonist Loaded Onto Protein Corona of Gold Nanoparticles, International Journal of Nanomedicine (2020)
44. Protein Corona: The Golden Gate to Clinical Applications of Nanoparticles, International Journal of Biochemistry and Cell Biology (2016)
45. Characterization of Protein Corona Formation on Nanoparticles Via the Analysis of Dynamic Interfacial Properties: Bovine Serum Albumin - Silica Particle Interaction, Colloids and Surfaces A: Physicochemical and Engineering Aspects (2022)
46. Nanomedicine and Chemotherapeutics Drug Delivery: Challenges and Opportunities, Journal of Drug Targeting (2021)
47. Could Artificial Intelligence Revolutionize the Development of Nanovectors for Gene Therapy and Mrna Vaccines?, Nano Today (2022)
48. Future Perspective on the Smart Delivery of Biomolecules, Drug Delivery Systems (2017)
49. Development of Novel Radiolabeled Antibody-Conjugated Graphene Quantum Dots for Targeted in Vivo Breast Cancer Imaging and Biodistribution Studies, Arabian Journal of Chemistry (2024)
50. Gd3+-Dtpa-Bis (N-Methylamine)–Dendrimer Significantly Alters Bax/Bcl2 Gene Expression Levels in Mcf-7 Cancer Cells, Biomedical Research (India) (2017)